Comparison of Active Surveillance to Stereotactic Radiosurgery for the Management of Patients with an Incidental Frontobasal Meningioma-A Sub-Analysis of the IMPASSE Study
Status PubMed-not-MEDLINE Jazyk angličtina Země Švýcarsko Médium electronic
Typ dokumentu časopisecké články
PubMed
35267608
PubMed Central
PMC8909178
DOI
10.3390/cancers14051300
PII: cancers14051300
Knihovny.cz E-zdroje
- Klíčová slova
- asymptomatic, incidental, meningioma, radiosurgery, surveillance,
- Publikační typ
- časopisecké články MeSH
Meningioma is a common incidental finding, and clinical course varies based on anatomical location. The aim of this sub-analysis of the IMPASSE study was to compare the outcomes of patients with an incidental frontobasal meningioma who underwent active surveillance to those who underwent upfront stereotactic radiosurgery (SRS). Data were retrospectively collected from 14 centres. The active surveillance (n = 28) and SRS (n = 84) cohorts were compared unmatched and matched for age, sex, and duration of follow-up (n = 25 each). The study endpoints included tumor progression, new symptom development, and need for further intervention. Tumor progression occurred in 52.0% and 0% of the matched active surveillance and SRS cohorts, respectively (p < 0.001). Five patients (6.0%) treated with SRS developed treatment related symptoms compared to none in the active monitoring cohort (p = 0.329). No patients in the matched cohorts developed symptoms attributable to treatment. Three patients managed with active surveillance (10.7%, unmatched; 12.0%, matched) underwent an intervention for tumor growth with no persistent side effects after treatment. No patients subject to SRS underwent further treatment. Active monitoring and SRS confer a similarly low risk of symptom development. Upfront treatment with SRS improves imaging-defined tumor control. Active surveillance and SRS are acceptable treatment options for incidental frontobasal meningioma.
Centre de Recherche du CHUS Université de Sherbrooke Sherbrooke QC J1H 5N4 Canada
Department of Neurological Surgery University of Virginia Charlottesville VA 22903 USA
Department of Neurosurgery Ain Shams University Cairo 11566 Egypt
Department of Neurosurgery and Radiation Oncology New York University New York NY 10016 USA
Department of Neurosurgery Benha University Benha 13512 Egypt
Department of Neurosurgery Koc University School of Medicine Istanbul 34010 Turkey
Department of Neurosurgery National Yang Ming University Beitou District Taipei City 11221 Taiwan
Department of Neurosurgery New York University New York NY 10016 USA
Department of Neurosurgery The Walton Centre NHS Foundation Trust Liverpool L9 7LJ UK
Department of Neurosurgery University of Miami Miller School of Medicine Miami FL 33136 USA
Department of Neurosurgery University of Pittsburgh Pittsburgh PA 15260 USA
Department of Radiation Oncology National Cancer Institute Cairo University Cairo 12613 Egypt
Department of Radiosurgery Rúber International Hospital 28034 Madrid Spain
Gamma Knife Center Cairo Nasser Institute Cairo 11796 Egypt
Institute of Systems Molecular and Integrative Biology University of Liverpool Liverpool L69 7BE UK
Zobrazit více v PubMed
Morris Z., Whiteley W.N., Longstreth W.T., Weber F., Lee Y.-C., Tsushima Y., Alphs H., Ladd S.C., Warlow C., Wardlaw J.M., et al. Incidental findings on brain magnetic resonance imaging: Systematic review and meta-analysis. BMJ. 2009;339:b3016. doi: 10.1136/bmj.b3016. PubMed DOI PMC
Bos D., Poels M.M.F., Adams H.H.H., Akoudad S., Cremers L.G.M., Zonneveld H.I., Hoogendam Y.Y., Verhaaren B., Verlinden V.J.A., Verbruggen J.G.J., et al. Prevalence, Clinical Management, and Natural Course of Incidental Findings on Brain MR Images: The Population-based Rotterdam Scan Study. Radiology. 2016;281:507–515. doi: 10.1148/radiol.2016160218. PubMed DOI
EANO Guideline on the Diagnosis and Management of Meningiomas|Neuro-Oncology|Oxford Academic. [(accessed on 15 October 2021)]. Available online: https://academic.oup.com/neuro-oncology/advance-article-abstract/doi/10.1093/neuonc/noab150/6310843?redirectedFrom=fulltext. PubMed DOI PMC
Behbahani M., Skeie G.O., Eide G.E., Hausken A., Lund-Johansen M., Skeie B.S. A prospective study of the natural history of incidental meningioma—Hold your horses! Neuro-Oncol. Pract. 2019;6:438–450. doi: 10.1093/nop/npz011. PubMed DOI PMC
Brugada-Bellsolà F., Teixidor Rodríguez P., Rodríguez-Hernández A., Garcia-Armengol R., Tardáguila M., González-Crespo A., Domínguez C.J., Rimbau J.M. Growth prediction in asymptomatic meningiomas: The utility of the AIMSS score. Acta Neurochir. 2019;161:2233–2240. doi: 10.1007/s00701-019-04056-3. PubMed DOI
Islim A.I., Kolamunnage-Dona R., Mohan M., Moon R.D.C., Crofton A., Haylock B.J., Rathi N., Brodbelt A.R., Mills S.J., Jenkinson M.D. A prognostic model to personalize monitoring regimes for patients with incidental asymptomatic meningiomas. Neuro-Oncology. 2020;22:278–289. doi: 10.1093/neuonc/noz160. PubMed DOI PMC
Clark V.E., Erson-Omay E.Z., Serin A., Yin J., Cotney J., Ozduman K., Avşar T., Li J., Murray P.B., Henegariu O., et al. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO. Science. 2013;339:1077–1080. doi: 10.1126/science.1233009. PubMed DOI PMC
Meling T.R., Da Broi M., Scheie D., Helseth E. Meningiomas: Skull base versus non-skull base. Neurosurg. Rev. 2019;42:163–173. doi: 10.1007/s10143-018-0976-7. PubMed DOI
Islim A.I., Mohan M., Moon R.D.C., Srikandarajah N., Mills S.J., Brodbelt A.R., Jenkinson M.D. Incidental intracranial meningiomas: A systematic review and meta-analysis of prognostic factors and outcomes. J. Neurooncol. 2019;142:211–221. doi: 10.1007/s11060-019-03104-3. PubMed DOI PMC
Pinzi V., Biagioli E., Roberto A., Galli F., Rizzi M., Chiappa F., Brenna G., Fariselli L., Floriani I. Radiosurgery for intracranial meningiomas: A systematic review and meta-analysis. Crit. Rev. Oncol. Hematol. 2017;113:122–134. doi: 10.1016/j.critrevonc.2017.03.005. PubMed DOI
Sheehan J.P., Starke R.M., Kano H., Kaufmann A.M., Mathieu D., Zeiler F.A., West M., Chao S.T., Varma G., Chiang V.L.S., et al. Gamma Knife radiosurgery for sellar and parasellar meningiomas: A multicenter study: Clinical article. J. Neurosurg. 2014;120:1268–1277. doi: 10.3171/2014.2.JNS13139. PubMed DOI
Gande A., Kano H., Bowden G., Mousavi S.H., Niranjan A., Flickinger J.C., Lunsford L.D. Gamma Knife radiosurgery of olfactory groove meningiomas provides a method to preserve subjective olfactory function. J. Neurooncol. 2014;116:577–583. doi: 10.1007/s11060-013-1335-8. PubMed DOI
Sheehan J., Pikis S., Islim A.I., Chen C.-J., Bunevicius A., Peker S., Samanci Y., Nabeel A.M., Reda W.A., Tawadros S.R., et al. An International Multicenter Matched Cohort Analysis of Incidental Meningioma Progression during Active Surveillance or after Stereotactic Radiosurgery: The IMPASSE Study. Neuro-Oncology. 2021;24:116–124. doi: 10.1093/neuonc/noab132. PubMed DOI PMC
Proposed Response Assessment and Endpoints for Meningioma Clinical Trials: Report from the Response Assessment in Neuro-Oncology Working Group|Neuro-Oncology|Oxford Academic. [(accessed on 15 October 2021)]. Available online: https://academic.oup.com/neuro-oncology/article/21/1/26/5076187. PubMed PMC
Yao X., Wei T., Zhang H., Li J., Tang A., Ren K. The Natural Growth Rate of Skull Base Meningiomas Compared with Non-Skull Base Meningiomas. J. Craniofac. Surg. 2019;30:1231–1233. doi: 10.1097/SCS.0000000000005468. PubMed DOI
Slower growth of skull base meningiomas compared with non–skull base meningiomas based on volumetric and biological studies in. [(accessed on 15 October 2021)];J. Neurosurg. 2012 116:574–580. doi: 10.3171/2011.11.JNS11999. Available online: https://thejns.org/view/journals/j-neurosurg/116/3/article-p574.xml. PubMed DOI
Kreßner M., Arlt F., Riepl W., Meixensberger J. Prognostic factors of microsurgical treatment of intracranial meningiomas—A multivariate analysis. PLoS ONE. 2018;13:e0202520. doi: 10.1371/journal.pone.0202520. PubMed DOI PMC